AddTweet Post to Facebook hEmail this
‹‹ Go Back

Charles W. Schauberger, MD, MS, CPE

Obstetrician/Gynecologist, Gundersen Health System, Onalaska, Wisconsin

presenter photoDr Charles Schauberger is an obstetrician who practices at Gundersen Health System in La Crosse, Wisconsin. He attended University of Iowa Medical School and completed a residency in Obstetrics & Gynecology at the same location many years ago. He received a MS in Administrative Medicine from the University of Wisconsin- Madison. He has published over 40 articles in the peer review literature. He is passionate about the care of pregnant women with addictions.

‹‹ Go Back

Mishka Terplan, MD, MPH, FACOG, FASAM

Medical Director, Behavioral Health System Baltimore, Baltimore, Maryland

Dr Terplan is board certified in both obstetrics and gynecology and addiction medicine and currently serves as the medical director of Behavioral Health System Baltimore. He completed his medical degree at the University of California, San Francisco and his Residency in obstetrics and gynecology at the University of Southern California, Los Angeles County Hospital. After residency he completed the TECT (Training in Epidemiology and Clinical Trials) fellowship at the University of North Carolina, Chapel Hill where he obtained a Master of Public Health in epidemiology. Prior to coming to BHS Baltimore he was on faculty at the University of Chicago and, more recently, at the University of Maryland. His clinical work and research has focused on the intersection of reproductive health and addictions.

‹‹ Go Back

Tricia E. Wright, MD MS

Assistant Professor, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii

presenter photoTricia Wright, MD MS is an assistant professor of Obstetrics, Gynecology and Women’s Health at the University of Hawaii John A. Burns School of Medicine and founder, former medical director, and now Women’s Health Liaison of the PATH Clinic, an outreach clinic of Waikiki Health Center, which provides prenatal, postpartum and family planning to women with a history of substance use disorders. She is board certified in both Ob/Gyn and Addiction Medicine and a Fellow of the American College of Obstetrics and Gynecology. She has been waivered to provide buprenorphine since 2009, and has treated both pregnant and non-pregnant women. She won funding approval in 2006 from the Hawaii legislature to start a perinatal clinic for women with substance use, the first in the state. The Path Clinic opened in 2007, and has seen over 400 pregnant women since that time. She completed her Masters Degree in Clinical Research from the University of Hawaii in 2009, her thesis paper studying the disparities of smoking and drug use rates during pregnancy of Native Hawaiian women. Her research interests include substance use disorders among pregnant women, including barriers to family planning, screening, brief intervention and referral to treatment (SBIRT), best practices for treatment, and the effects of methamphetamine, marijuana and tobacco on the placenta.

‹‹ Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

Workshop Track

Best practices for the care of the pregnant women with addictions

Best Practices for the Care of Pregnant Women with Addiction

4/24/2015

2:00 PM - 3:00 PM

Room: Governors Ballroom D, Fourth Floor

Organizer (Presenting)(s):

Charles W. Schauberger, MD, MS, CPE

Obstetrician/Gynecologist, Gundersen Health System, Onalaska, Wisconsin

Presenter(s):

Mishka Terplan, MD, MPH, FACOG, FASAM

Medical Director, Behavioral Health System Baltimore, Baltimore, Maryland

Tricia E. Wright, MD MS

Assistant Professor, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii

Addiction care and prenatal care can represent a significant challenge for both obstetricians and addiction specialists. The size of this population is growing and standards of care are in the early stages of development. A panel will discuss the current level of scientific support for current recommendations for care of women with drug addictions in pregnancy. Panel experts will discuss: screening obstetrical populations for drug use in early pregnancy, initiation of prenatal care, screening and management of comorbidities, co-management with behavioral medicine and addiction specialists, how pregnancy affects addiction care, and the safe management of labor, delivery and postpartum. The authors plan to present their protocols for the management of these patients, utilizing the best evidence in the literature to support their practices.